Arrowhead Pharmaceuticals (ARWR) Capital Leases (2011 - 2016)
Arrowhead Pharmaceuticals' Capital Leases came in at $378,862 for fiscal Q3 2016 (quarter ended Jun 30, 2016), down 36.4% from $595,516 a year earlier and down 12.0% from the prior quarter.
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Capital Leases (2011 - 2016) Analysis & Trends
At the end of FY2015 (ended Sep 30, 2015), Arrowhead Pharmaceuticals' Capital Leases was $540,792, down 28.7% from FY2014.
- Capital Leases has declined in each of the last three fiscal years, with a three-year compound annual growth rate of -25.0% (FY2012 to FY2015).
- Going back by fiscal year, Capital Leases was $758,340 in FY2014 (-28.5%), $1.06 million in FY2013 (-17.3%) and $1.28 million in FY2012.
- The fiscal Q3 2016 figure represents the lowest quarterly Capital Leases in data going back to fiscal Q1 2012.
- Year-over-year, Capital Leases has declined for 15 consecutive quarters, with an average decline of 30.0% over the last eight quarters.
- Over the past five years, the year-over-year decline in Capital Leases ranged from 15.0% (fiscal Q1 2013) to 36.4% (fiscal Q3 2016).
- Business Quant data shows ARWR's Capital Leases at $430,665 (Q2 2016), $485,842 (Q1 2016) and $540,792 (Q4 2015) in the three fiscal quarters before Q3 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.19 Bn | 1,101.77 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 616.03 Bn | 534.56 Bn | 17.26 Bn |
| 3 | AbbVie | 501.09 Bn | 474.20 Bn | 12.70 Bn |
| 4 | Merck | 366.82 Bn | 321.20 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.82 Bn | 261.81 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.33 Bn | 235.02 Bn | 12.86 Bn |
| 7 | Amgen | 235.89 Bn | 191.29 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.64 Bn | 164.84 Bn | 6.22 Bn |
| 9 | Pfizer | 169.32 Bn | 115.96 Bn | 10.94 Bn |
| 10 | Arrowhead Pharmaceuticals | 8.57 Bn | 3.35 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2016 | 378,862.00 |
| Mar 31, 2016 | 430,665.00 |
| Dec 31, 2015 | 485,842.00 |
| Sep 30, 2015 | 540,792.00 |
| Jun 30, 2015 | 595,516.00 |
| Mar 31, 2015 | 650,014.00 |
| Dec 31, 2014 | 705,173.00 |
| Sep 30, 2014 | 758,340.00 |
| Jun 30, 2014 | 812,169.00 |
| Mar 31, 2014 | 865,777.00 |
| Dec 31, 2013 | 1.01 Mn |
| Sep 30, 2013 | 1.06 Mn |
| Jun 30, 2013 | 1.12 Mn |
| Mar 31, 2013 | 1.17 Mn |
| Dec 31, 2012 | 1.23 Mn |
| Sep 30, 2012 | 1.28 Mn |
| Jun 30, 2012 | 1.34 Mn |
| Mar 31, 2012 | 1.39 Mn |
| Dec 31, 2011 | 1.44 Mn |
API Access
Arrowhead Pharmaceuticals Capital Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-leases&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-leases", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-leases&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();